The present invention relates generally to luer activated devices or valves that allow for the bi-directional transfer of fluids to and from medical fluid flow systems.
Luer activated devices (LAD) or valves (LAV) are commonly used in association with medical fluid containers and medical fluid flow systems that are connected to patients or other subjects undergoing diagnostic, therapeutic or other medical procedures. A LAD can be attached to or part of a fluid container or a medical fluid flow system to simplify the addition of fluids to or withdrawal of fluids from the fluid flow system.
Within the medical field there are a wide variety of medical fluid flow systems, serving a variety of functions. One of the more common uses of LADs are in association with fluid flow systems that are used for the intravenous administration of fluids, such as saline, antibiotics, or any number of other medically-related fluids, to a patient. These flow systems are commonly referred to as intravenous or “IV” fluid administration sets, and use plastic tubing to connect a phlebotomized subject to one or more medical fluid sources, such as intravenous solution or medicament containers.
Typically, such intravenous administration sets include one or more LADs providing needless access to the fluid flow path to allow fluid to be added to or withdrawn from the IV tubing. The absence of a needle for injecting or withdrawing fluid has the important advantage of reducing the incidence of needle stick injuries to medical personnel. A LAD typically includes a tapered female luer component, such as the inlet into a valve housing, that accepts and mates with a tapered male luer of a medical infusion or aspiration device, such as a needleless syringe or a administration set tubing brand.
There are certain characteristics and qualities of LADs that are highly desirable. For example, the LAD should provide a sufficient microbial barrier for the full service life of the valve. It is desirable that the microbial barrier be conducive to the application of standard aseptic techniques preformed by clinicians during the use of the device. For example, the geometry of the LAD should be such that it is easily swabbable and reduces the potential of entrapping particulates or contaminants that cannot be cleanly swabbed clear prior to use. In addition, the LAD should not permit cross contamination between the male luer and the surfaces of the aseptic fluid path.
Furthermore, it is highly desirable that the LAD be substantially devoid of any interstitial space or any other “dead space” that cannot be flushed, or that such interstitial space be physically isolated from the fluid flow path. Such interstitial space has the potential of providing an environment for undesired microbial growth. In addition, the LAD should have a geometry that allows it to be sufficiently flushed so as to clear the dynamic fluid path and adjacent areas of residual blood or intravenous fluids to prevent undesired microbial growth.
LAD's are commonly used with intravenous catheters that provide access to a patient's vascular system. In such systems, another desirable feature of a LAD is minimal displacement of fluid during insertion and removal of the male luer. In certain situations, it is preferable that the LAD be a neutral/neutral device in that there is zero or only a very slight displacement of fluid during both insertion and removal of the male luer. In other situations it can be desirable for the LAD to produce a positive displacement of fluid from the valve housing during the insertion and removal of the male luer. The LAD also preferably prevents blood reflux into the catheter. Reflux is known to reduce the efficiency of the catheter, contribute to catheter clotting and also contribute to catheter related bloodstream infections.
In most situations it is preferred that the LAD be ergonomically dimensioned to be completely activated by a wide range of ISO compliant male luer lock adaptors. However, there may some instances when the LAD is specifically designed to be activated by a male luer lock that is not ISO complaint. Another desirable characteristic of a LAD is the ability of the LAD to seal against pressure contained within a fluid system to which the LAD is connected. For example, it is desirable to be leak resistance to positive pressures ranging from 10 to 45 psi and to negative pressures or vacuum from 1 to 5 psi. The LAD also preferably has a geometry that allows for easy priming and flushing that does not require any additional manipulations to remove residual air bubbles from the tubing system.
These and other desirable characteristics, which may be used separately or in combination, is preferably present over the full service life of the valve. When used in connection with an IV set or catheter, the LAD may go through many connections and disconnections. It is desirable that the life of an LAD last through upwards to about 100 connections and disconnections or 96 hours of dwell time.
As described more fully below, the fluid access devices of the present invention provides important advances in the safe and efficient administration or withdrawal of medical fluids to or from a fluid flow system.
In accordance with one aspect of the present invention, a medical valve for the bi-directional transfer of fluid is provided with a valve housing having an inlet adapted for receiving a male luer, an outlet and a passageway therethrough. A fluid flow controller is received within the valve housing and has a valve element fixedly attached to the inlet. The valve element has a resealable aperture for receiving a male luer and sealing the inlet. An extending portion extends away from the valve element and is fixedly attached to the outlet to define a fluid flow path in communication with the aperture and the outlet. The fluid flow controller is maintained in a tensioned state within the valve housing, such that insertion of a male luer into the inlet decreases the tension in at least a portion of the fluid flow controller.
According to another aspect of the present invention, a medical valve for the bi-directional transfer of fluid is provided with a valve housing having an inlet adapted for receiving a male luer. A fluid flow controller associated with the valve housing has a valve element fixedly attached to the inlet in a tensioned state. The valve element has a first sealing layer defining a first resealable aperture, a second sealing layer defining a second resealable aperture, and a channel therebetween and in communication with both apertures. The channel is substantially closed in the tensioned state and open in an untensioned state.
According to yet another aspect of the present invention, a method of manufacturing a medical valve involves providing a fluid flow controller having a valve element and an extending portion defining a fluid flow path. The valve element is fixedly attached to an upper portion of a valve housing so as to seal an inlet of the upper housing portion. The fluid flow controller is stretched away from the inlet and a lower housing portion is placed over the extending portion of the fluid flow controller so that the extending portion extends into an outlet of the lower housing portion. The lower housing portion is fixedly attached to the lower housing portion and a section of the extending portion is fixedly attached to the outlet, thereby maintaining the fluid flow controller in a tensioned state.
Turning now to a more detailed description of the various embodiments of the present invention illustrated in the attached drawings, of which:
As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific details disclosed herein are not to be interpreted as limiting, but merely as a basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriate manner.
The outlet 20 is adapted to be connected to any of a number of fluid flow systems, so the exact configuration of the outlet 20 will vary according to the nature of the fluid flow system to which it is to be connected. For example, the illustrated outlet 20 is suitable for use in connecting the valve 10 to an IV administrative tubing set (not illustrated). In the embodiment of
The inlet 18 includes an opening 28 adapted to receive a male luer 30 (
The male luer 30 has a hollow channel 32 defined by a generally tubular wall 34. The wall 34 preferably has a substantially smooth outer surface 36 which is typically cylindrical or conical. The inlet 18 may include external threads 38, in which case a portion of the luer wall 34 may be surrounded by a collar member 40 (
By way of example, the collar member 40 and luer wall 34 may be configured to provide a tactile feel when the male luer 30 has been fully engaged to the LAD 10. As shown in shadow in
The inlet 18 fixedly receives a fluid flow controller 44 having a resealable slit or aperture 46 therethrough. The flow controller 44 acts as a microbial barrier between the internal passageway 22 of the LAD 10 and the atmosphere. The flow controller 44 may include a substantially concave upper surface 48 (
The flow controller 44 is comprised of a first portion or valve element 50, which includes the upper surface 48 and the aperture 46, and a second portion or extending portion 52 (
Preferably, the flow controller 44 is molded as a unitary piece, typically from a deformable elastomeric material, such as silicone or rubber or santoprene. The “as-molded” configuration of the flow controller 44 is shown in
It will be seen that the flow controller 44 is significantly shorter in the “as-molded” configuration of
When the valve element 50 has been secured to the inlet 18, an elongated mandrel or vacuum member 62 is inserted through the aperture 46 and the fluid flow path 54 (
With the mandrel 62 still in place and providing a suction force, the lower valve housing portion 16 is slid over the extending portion 52 and affixed to the upper housing portion 14 (
In an alternate embodiment, the extending portion 52 may be directly attached to the lower valve housing portion 52 by over-molding.
Turning now to the operation of the LAD 10, a male luer 30 is inserted into the inlet 18 and through the aperture 46 (
The male luer 30 is further inserted into the aperture 46 until the aperture 46 completely opens and allows a portion of the male luer 30 to move into the extending portion 52. The outer radius of the male luer 30 is larger than the inner radius of the fluid flow path 54, which causes the portion of the wall 58 between the bulge 60 and the male luer 30 to bend outward into a generally frusto-conical shape defining a fluid reservoir 64 (
The difference between the first volume V (
As with the embodiment of
When the valve element 50 has been secured to the inlet 18, an elongated mandrel or vacuum member 62 is inserted through the aperture 46 and the fluid flow path 54 (
With the mandrel 62 still in place and providing a suction force, the restrictor member 66 is slid over the extending portion 52 and into the position of
As described in greater detail herein, the flange 74 has the tendency to resiliently return to the relaxed condition when the mandrel 62 is removed from the LAD 10a. Accordingly, the flange 74 is preferably comprised of a material more rigid than the elastomeric material of the flow controller 44a (to pinch the fluid flow path 54 closed), but sufficiently pliable to move between the relaxed condition of
When the restrictor member 66 has been properly positioned within the upper housing portion 14, the lower valve housing portion 16 is slid over the extending portion 52 and affixed to the upper housing portion 52 (
A portion of the mandrel 62 and the extending portion 52 remains outside of the lower housing portion 16. A bushing member 56 is affixed to this portion of the extending portion 52 (
Turning now to the operation of the LAD 10a, a male luer 30 is partially inserted into the inlet 18 and through the aperture 46 (
Similarly upon withdrawal of the male luer 30, as the male luer is withdrawn the male luer no longer engages the section of the fluid flow path 54 adjacent the restrictor member 66 and the restrictor member then closes the flow path. Further withdrawal of the male luer will create a vacuum condition in the flow path 54 which pulls fluid from within the male luer. This reduces aersolization of fluid from the male luer tip.
As with the embodiment of
With the flow controller 44b in an “as-molded” configuration, the modified valve element 80 is secured to the LAD inlet 18 (
When the first sealing layer 48 is securely seated, the rim 88 is positioned to abut a shoulder 70 of the upper housing portion 14. The rim 88 may be affixed to the shoulder 70 by a variety of means, depending on the material selected for the housing upper portion 14 and the flow controller 44b. Suitable means may include welding, adhesion, and a press fit with the lower housing portion 16, as described in greater detail herein.
Preferably, the distance between the top of the upper surface 48 and the rim 88 is less than the height of the inlet 18, such that the channel 90 must be stretched to properly position the first and second sealing layers 48 and 86.
When the modified valve element 80 has been secured to the inlet 18, an elongated mandrel or vacuum member 62 is inserted through the apertures 46 and 82, the channel 90, and the fluid flow path 54 (
With the mandrel 62 still in place and providing a suction force, the lower housing portion 16 is slid over the extending portion 52 and affixed to the upper housing portion 14 (
A portion of the mandrel 62 and the extending portion 52 remains outside of the lower housing portion 16. A bushing member 56 is affixed to this portion of the extending portion 52 (
Turning now to the operation of the LAD 44b, a male luer 30 is partially inserted into the inlet 18 and through the first aperture 46 (
As the male luer 30 is further inserted into the inlet 18, it continues to deform the flow controller 44b, which causes the bulge 60 to reemerge, and opens the second aperture 82 (
It will be appreciated that the embodiment of
The flow controller 44b of
Referring in particular to
While the present invention has been described in terms of certain preferred and alternative embodiments for purposes of illustration, it is not limited to the precise embodiments shown or to the particular features, shapes or sizes illustrated. A variety of changes may be made without departing from the present invention as defined by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4176588 | Baron | Dec 1979 | A |
4334551 | Pfister | Jun 1982 | A |
4413462 | Rose | Nov 1983 | A |
4475548 | Muto | Oct 1984 | A |
4691929 | Neumaier et al. | Sep 1987 | A |
4928212 | Benavides | May 1990 | A |
4943896 | Johnson | Jul 1990 | A |
4946445 | Lynn | Aug 1990 | A |
4964855 | Todd et al. | Oct 1990 | A |
4973443 | Larson et al. | Nov 1990 | A |
4998713 | Vaillancourt | Mar 1991 | A |
4998927 | Vaillancourt | Mar 1991 | A |
5009490 | Kouno et al. | Apr 1991 | A |
5019325 | Larson et al. | May 1991 | A |
5046456 | Heyman et al. | Sep 1991 | A |
D321250 | Jepson et al. | Oct 1991 | S |
D321251 | Jepson et al. | Oct 1991 | S |
5064416 | Newgard et al. | Nov 1991 | A |
5065783 | Ogle, II | Nov 1991 | A |
5100394 | Dudar et al. | Mar 1992 | A |
5114408 | Fleischhaker et al. | May 1992 | A |
5122123 | Vaillancourt | Jun 1992 | A |
5135489 | Jepson et al. | Aug 1992 | A |
5154703 | Bonaldo | Oct 1992 | A |
5158554 | Jepson et al. | Oct 1992 | A |
5171234 | Jepson et al. | Dec 1992 | A |
5188620 | Jepson et al. | Feb 1993 | A |
5199947 | Lopez et al. | Apr 1993 | A |
5201717 | Wyatt et al. | Apr 1993 | A |
5203775 | Frank et al. | Apr 1993 | A |
5211638 | Dudar et al. | May 1993 | A |
5242393 | Brimhall et al. | Sep 1993 | A |
5242425 | White et al. | Sep 1993 | A |
5242432 | DeFrank | Sep 1993 | A |
5251873 | Atkinson et al. | Oct 1993 | A |
5256155 | Yerlikaya et al. | Oct 1993 | A |
5269763 | Boehmer et al. | Dec 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5280876 | Atkins | Jan 1994 | A |
5290254 | Vaillancourt | Mar 1994 | A |
5295657 | Atkinson | Mar 1994 | A |
5295658 | Atkinson et al. | Mar 1994 | A |
5312377 | Dalton | May 1994 | A |
5323264 | Kato | Jun 1994 | A |
5324270 | Kayan et al. | Jun 1994 | A |
5344414 | Lopez et al. | Sep 1994 | A |
5360413 | Leason et al. | Nov 1994 | A |
5401245 | Haining | Mar 1995 | A |
5402982 | Atkinson et al. | Apr 1995 | A |
5411499 | Dudar et al. | May 1995 | A |
5417673 | Gordon | May 1995 | A |
5470319 | Mayer | Nov 1995 | A |
5487731 | Denton | Jan 1996 | A |
5514109 | Mollenauer et al. | May 1996 | A |
5533708 | Atkinson et al. | Jul 1996 | A |
5540661 | Tomisaka et al. | Jul 1996 | A |
5549566 | Elias et al. | Aug 1996 | A |
5549651 | Lynn | Aug 1996 | A |
5556388 | Johlin, Jr. | Sep 1996 | A |
5578059 | Patzer | Nov 1996 | A |
5602016 | Isogai et al. | Feb 1997 | A |
5609584 | Gettig et al. | Mar 1997 | A |
5616129 | Mayer | Apr 1997 | A |
5616130 | Mayer | Apr 1997 | A |
5676346 | Leinsing | Oct 1997 | A |
5677141 | Isogai et al. | Oct 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5690612 | Lopez et al. | Nov 1997 | A |
5695466 | Lopez et al. | Dec 1997 | A |
5699821 | Paradis | Dec 1997 | A |
5700248 | Lopez | Dec 1997 | A |
5730418 | Feith et al. | Mar 1998 | A |
5738663 | Lopez | Apr 1998 | A |
5773272 | Isogai et al. | Jun 1998 | A |
RE35841 | Frank et al. | Jul 1998 | E |
5788675 | Mayer | Aug 1998 | A |
5797897 | Jepson et al. | Aug 1998 | A |
5820601 | Mayer | Oct 1998 | A |
5836923 | Mayer | Nov 1998 | A |
5865807 | Blake, III | Feb 1999 | A |
5873862 | Lopez | Feb 1999 | A |
5901942 | Lopez | May 1999 | A |
5928204 | Lopez | Jul 1999 | A |
5957898 | Jepson et al. | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
5971965 | Mayer | Oct 1999 | A |
RE36587 | Tanaka et al. | Feb 2000 | E |
6019748 | Lopez | Feb 2000 | A |
6029946 | Doyle | Feb 2000 | A |
6036171 | Weinheimer et al. | Mar 2000 | A |
6039302 | Cote, Sr. et al. | Mar 2000 | A |
RE36661 | Tanaka et al. | Apr 2000 | E |
6048335 | Mayer | Apr 2000 | A |
6089541 | Weinheimer et al. | Jul 2000 | A |
6113068 | Ryan | Sep 2000 | A |
6132403 | Lopez | Oct 2000 | A |
6132404 | Lopez | Oct 2000 | A |
6146396 | Konya et al. | Nov 2000 | A |
6152900 | Mayer | Nov 2000 | A |
6162251 | Kredovski | Dec 2000 | A |
6171287 | Lynn et al. | Jan 2001 | B1 |
6177037 | Mayer | Jan 2001 | B1 |
6183448 | Mayer | Feb 2001 | B1 |
6187476 | Pyun et al. | Feb 2001 | B1 |
6210624 | Mayer | Apr 2001 | B1 |
6228069 | Barth et al. | May 2001 | B1 |
6245048 | Fangrow, Jr. et al. | Jun 2001 | B1 |
6261268 | Mayer | Jul 2001 | B1 |
6261282 | Jepson et al. | Jul 2001 | B1 |
6290206 | Doyle | Sep 2001 | B1 |
6299132 | Weinheimer et al. | Oct 2001 | B1 |
6325782 | Lopez | Dec 2001 | B1 |
6341802 | Matkovich | Jan 2002 | B1 |
6344033 | Jepson et al. | Feb 2002 | B1 |
6355023 | Roth et al. | Mar 2002 | B1 |
6364869 | Bonaldo | Apr 2002 | B1 |
6374876 | Bynum | Apr 2002 | B2 |
6383168 | Landau et al. | May 2002 | B1 |
6390120 | Guala | May 2002 | B1 |
6390130 | Guala | May 2002 | B1 |
6394983 | Mayoral et al. | May 2002 | B1 |
6394992 | Sjoholm | May 2002 | B1 |
6402723 | Lampropoulos | Jun 2002 | B1 |
6408897 | Laurent et al. | Jun 2002 | B1 |
6409707 | Guala | Jun 2002 | B1 |
6409708 | Wessman | Jun 2002 | B1 |
6423053 | Lee | Jul 2002 | B1 |
6428520 | Lopez et al. | Aug 2002 | B1 |
6440107 | Trombley, III et al. | Aug 2002 | B1 |
6467732 | Tsukahara | Oct 2002 | B2 |
6481756 | Field et al. | Nov 2002 | B1 |
6482188 | Rogers et al. | Nov 2002 | B1 |
6485472 | Richmond | Nov 2002 | B1 |
6486630 | Takagi | Nov 2002 | B2 |
6491668 | Paradis | Dec 2002 | B1 |
6508807 | Peters | Jan 2003 | B1 |
6520932 | Taylor | Feb 2003 | B2 |
6536805 | Matkovich | Mar 2003 | B2 |
6537258 | Guala | Mar 2003 | B1 |
6539248 | Moroski | Mar 2003 | B1 |
6541802 | Doyle | Apr 2003 | B2 |
6543745 | Enerson | Apr 2003 | B1 |
6544236 | Cragg et al. | Apr 2003 | B1 |
6569118 | Johnson et al. | May 2003 | B2 |
6569125 | Jepson et al. | May 2003 | B2 |
RE38145 | Lynn | Jun 2003 | E |
6572590 | Stevens et al. | Jun 2003 | B1 |
6572591 | Mayer | Jun 2003 | B2 |
6572592 | Lopez | Jun 2003 | B1 |
6581906 | Pott et al. | Jun 2003 | B2 |
6585229 | Cote, Sr. et al. | Jul 2003 | B2 |
6595954 | Luther et al. | Jul 2003 | B1 |
6595964 | Finley et al. | Jul 2003 | B2 |
6599273 | Lopez | Jul 2003 | B1 |
6605076 | Jepson et al. | Aug 2003 | B1 |
6609696 | Enerson | Aug 2003 | B2 |
6620119 | Utterberg et al. | Sep 2003 | B1 |
6626418 | Kiehne | Sep 2003 | B2 |
6634033 | Mizuno et al. | Oct 2003 | B2 |
6635044 | Lopez | Oct 2003 | B2 |
6638244 | Reynolds | Oct 2003 | B1 |
6638258 | Schwartz et al. | Oct 2003 | B2 |
6651956 | Miller | Nov 2003 | B2 |
6655655 | Matkovich et al. | Dec 2003 | B1 |
6666839 | Utterberg et al. | Dec 2003 | B2 |
6669673 | Lopez | Dec 2003 | B2 |
6669681 | Jepson et al. | Dec 2003 | B2 |
6673059 | Guala | Jan 2004 | B2 |
6679529 | Johnson et al. | Jan 2004 | B2 |
6681810 | Weston | Jan 2004 | B2 |
6682509 | Lopez | Jan 2004 | B2 |
6695817 | Fangrow, Jr. | Feb 2004 | B1 |
6699222 | Jones et al. | Mar 2004 | B1 |
6706022 | Leinsing et al. | Mar 2004 | B1 |
6716187 | Jorgensen et al. | Apr 2004 | B1 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6722705 | Korkor | Apr 2004 | B2 |
6723074 | Halseth | Apr 2004 | B1 |
6726651 | Robinson et al. | Apr 2004 | B1 |
6726672 | Hanly et al. | Apr 2004 | B1 |
6730883 | Brown et al. | May 2004 | B2 |
6745998 | Doyle | Jun 2004 | B2 |
6746438 | Arnissolle | Jun 2004 | B1 |
6755391 | Newton et al. | Jun 2004 | B2 |
6758833 | Lopez | Jul 2004 | B2 |
6770051 | Hughes et al. | Aug 2004 | B2 |
6802490 | Leinsing et al. | Oct 2004 | B2 |
6802836 | Bouphavichith et al. | Oct 2004 | B2 |
6808161 | Hishikawa | Oct 2004 | B1 |
6808509 | Davey | Oct 2004 | B1 |
6811139 | Hishikawa | Nov 2004 | B2 |
6814726 | Lauer | Nov 2004 | B1 |
6827709 | Fujii | Dec 2004 | B2 |
6827710 | Mooney et al. | Dec 2004 | B1 |
6834842 | Houde | Dec 2004 | B2 |
6840501 | Doyle | Jan 2005 | B2 |
6843513 | Guala | Jan 2005 | B2 |
6866656 | Tingey et al. | Mar 2005 | B2 |
6869426 | Ganem | Mar 2005 | B2 |
6871087 | Hughes et al. | Mar 2005 | B1 |
6874522 | Anderson et al. | Apr 2005 | B2 |
6878905 | Brown et al. | Apr 2005 | B2 |
6880801 | Matkovich et al. | Apr 2005 | B2 |
6883778 | Newton et al. | Apr 2005 | B1 |
6893056 | Guala | May 2005 | B2 |
6902207 | Lickliter | Jun 2005 | B2 |
6908459 | Harding et al. | Jun 2005 | B2 |
6911025 | Miyahara | Jun 2005 | B2 |
6916309 | Fangrow, Jr. | Jul 2005 | B2 |
6918500 | Okiyama | Jul 2005 | B2 |
6932795 | Lopez et al. | Aug 2005 | B2 |
6953450 | Baldwin et al. | Oct 2005 | B2 |
6955669 | Curutcharry | Oct 2005 | B2 |
6960198 | Sarmiento | Nov 2005 | B2 |
6964406 | Doyle | Nov 2005 | B2 |
6969381 | Voorhees | Nov 2005 | B2 |
6972001 | Emig et al. | Dec 2005 | B2 |
6974446 | Hommann et al. | Dec 2005 | B2 |
6994315 | Ryan et al. | Feb 2006 | B2 |
7004934 | Vaillancourt | Feb 2006 | B2 |
7008406 | Mayer | Mar 2006 | B2 |
7014169 | Newton et al. | Mar 2006 | B2 |
7025744 | Utterberg et al. | Apr 2006 | B2 |
7033339 | Lynn | Apr 2006 | B1 |
7037302 | Vaillancourt et al. | May 2006 | B2 |
7041087 | Henderson et al. | May 2006 | B2 |
7044441 | Doyle | May 2006 | B2 |
7044937 | Kirwan et al. | May 2006 | B1 |
7081600 | Brown et al. | Jul 2006 | B2 |
7083605 | Miyahara | Aug 2006 | B2 |
7090191 | Matkovich et al. | Aug 2006 | B2 |
7097209 | Sparrman et al. | Aug 2006 | B2 |
7100891 | Doyle | Sep 2006 | B2 |
7104520 | Leinsing et al. | Sep 2006 | B2 |
RE39334 | Lynn | Oct 2006 | E |
7114701 | Peppel | Oct 2006 | B2 |
7118560 | Bonaldo | Oct 2006 | B2 |
7128348 | Kawamura et al. | Oct 2006 | B2 |
7137974 | Almasian et al. | Nov 2006 | B2 |
7140592 | Mitchell | Dec 2006 | B2 |
7153296 | Mitchell | Dec 2006 | B2 |
7156826 | Ishii et al. | Jan 2007 | B2 |
7160272 | Eyal et al. | Jan 2007 | B1 |
RE39499 | Racz | Feb 2007 | E |
7172572 | Diamond et al. | Feb 2007 | B2 |
7174923 | Schorn et al. | Feb 2007 | B2 |
7175615 | Hanly et al. | Feb 2007 | B2 |
7182313 | Doyle | Feb 2007 | B2 |
7184825 | Leinsing et al. | Feb 2007 | B2 |
7396348 | Newton et al. | Jul 2008 | B2 |
20010045539 | Doyle | Nov 2001 | A1 |
20010049508 | Fangrow et al. | Dec 2001 | A1 |
20010051791 | Azzolini | Dec 2001 | A1 |
20010051793 | Weston | Dec 2001 | A1 |
20020007157 | Azzolini | Jan 2002 | A1 |
20020024036 | Rohrbough et al. | Feb 2002 | A1 |
20020032433 | Lopez | Mar 2002 | A1 |
20020038114 | Segura | Mar 2002 | A1 |
20020062106 | Chu et al. | May 2002 | A1 |
20020082586 | Finley et al. | Jun 2002 | A1 |
20020099360 | Bierman | Jul 2002 | A1 |
20020108614 | Schultz | Aug 2002 | A1 |
20020115981 | Wessman | Aug 2002 | A1 |
20020115984 | Guala | Aug 2002 | A1 |
20020117645 | Kiehne | Aug 2002 | A1 |
20020128595 | Weston et al. | Sep 2002 | A1 |
20020128607 | Haury et al. | Sep 2002 | A1 |
20020133124 | Leinsing et al. | Sep 2002 | A1 |
20020138047 | Lopez | Sep 2002 | A1 |
20020143300 | Trombley et al. | Oct 2002 | A1 |
20020143301 | Lopez | Oct 2002 | A1 |
20020147429 | Cowan et al. | Oct 2002 | A1 |
20020147431 | Lopez et al. | Oct 2002 | A1 |
20020153503 | Newton et al. | Oct 2002 | A1 |
20020156431 | Feith et al. | Oct 2002 | A1 |
20020161334 | Castellano et al. | Oct 2002 | A1 |
20020193752 | Lynn | Dec 2002 | A1 |
20030028156 | Juliar | Feb 2003 | A1 |
20030032940 | Doyle | Feb 2003 | A1 |
20030036735 | Jepson et al. | Feb 2003 | A1 |
20030050610 | Newton et al. | Mar 2003 | A1 |
20030060779 | Richmond | Mar 2003 | A1 |
20030060804 | Vaillancourt | Mar 2003 | A1 |
20030066978 | Enerson | Apr 2003 | A1 |
20030066980 | Hishikawa | Apr 2003 | A1 |
20030085372 | Newton | May 2003 | A1 |
20030093061 | Ganem | May 2003 | A1 |
20030098430 | Leinsing et al. | May 2003 | A1 |
20030105452 | Mayer | Jun 2003 | A1 |
20030109853 | Harding et al. | Jun 2003 | A1 |
20030120221 | Vaillancourt | Jun 2003 | A1 |
20030127620 | Houde | Jul 2003 | A1 |
20030141477 | Miller | Jul 2003 | A1 |
20030144626 | Hanson et al. | Jul 2003 | A1 |
20030144647 | Miyahara | Jul 2003 | A1 |
20030181850 | Diamond et al. | Sep 2003 | A1 |
20030181854 | Sauvageau | Sep 2003 | A1 |
20030183795 | Doyle | Oct 2003 | A1 |
20030195478 | Russo | Oct 2003 | A1 |
20030199835 | Leinsing et al. | Oct 2003 | A1 |
20030208165 | Christensen et al. | Nov 2003 | A1 |
20030209681 | Leinsing et al. | Nov 2003 | A1 |
20030216712 | Kessler et al. | Nov 2003 | A1 |
20030225379 | Schaffer et al. | Dec 2003 | A1 |
20030236497 | Fremming et al. | Dec 2003 | A1 |
20040006330 | Fangrow | Jan 2004 | A1 |
20040019344 | Peterson et al. | Jan 2004 | A1 |
20040030321 | Fangrow | Feb 2004 | A1 |
20040068238 | Utterberg | Apr 2004 | A1 |
20040068239 | Utterberg | Apr 2004 | A1 |
20040073174 | Lopez | Apr 2004 | A1 |
20040073176 | Utterberg | Apr 2004 | A1 |
20040092886 | Mayer | May 2004 | A1 |
20040102738 | Dikeman et al. | May 2004 | A1 |
20040111078 | Miyahara | Jun 2004 | A1 |
20040116869 | Heinz et al. | Jun 2004 | A1 |
20040122418 | Voorhees | Jun 2004 | A1 |
20040124388 | Kiehne | Jul 2004 | A1 |
20040124389 | Phillips | Jul 2004 | A1 |
20040138641 | Patzer | Jul 2004 | A1 |
20040162517 | Furst et al. | Aug 2004 | A1 |
20040162540 | Walenciak et al. | Aug 2004 | A1 |
20040171993 | Bonaldo | Sep 2004 | A1 |
20040172006 | Bonaldo | Sep 2004 | A1 |
20040186458 | Hiejima et al. | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20040199126 | Harding et al. | Oct 2004 | A1 |
20040204699 | Hanly et al. | Oct 2004 | A1 |
20040206924 | Newton et al. | Oct 2004 | A1 |
20040210194 | Bonnette et al. | Oct 2004 | A1 |
20040225274 | Jansen et al. | Nov 2004 | A1 |
20040227120 | Raybuck | Nov 2004 | A1 |
20040236314 | Saab | Nov 2004 | A1 |
20040243065 | McConnell et al. | Dec 2004 | A1 |
20040243069 | Feith et al. | Dec 2004 | A1 |
20040243070 | Lopez | Dec 2004 | A1 |
20040249349 | Wentling | Dec 2004 | A1 |
20040254534 | Bjorkman et al. | Dec 2004 | A1 |
20040260243 | Rickerd | Dec 2004 | A1 |
20040260266 | Cuschieri et al. | Dec 2004 | A1 |
20050010168 | Kendall | Jan 2005 | A1 |
20050015070 | Delnevo et al. | Jan 2005 | A1 |
20050021000 | Adair et al. | Jan 2005 | A1 |
20050033267 | Decaria | Feb 2005 | A1 |
20050033268 | Decaria | Feb 2005 | A1 |
20050033269 | Decaria | Feb 2005 | A1 |
20050038397 | Newton et al. | Feb 2005 | A1 |
20050059952 | Giuliano et al. | Mar 2005 | A1 |
20050087715 | Doyle | Apr 2005 | A1 |
20050090805 | Shaw et al. | Apr 2005 | A1 |
20050096585 | Schon et al. | May 2005 | A1 |
20050107770 | Schweikert et al. | May 2005 | A1 |
20050119613 | Moenning et al. | Jun 2005 | A1 |
20050121638 | Doyle | Jun 2005 | A1 |
20050124935 | McMichael | Jun 2005 | A1 |
20050124942 | Richmond | Jun 2005 | A1 |
20050124943 | Yang | Jun 2005 | A1 |
20050151105 | Ryan et al. | Jul 2005 | A1 |
20050154372 | Minezaki | Jul 2005 | A1 |
20050159710 | Utterberg | Jul 2005 | A1 |
20050165365 | Newton et al. | Jul 2005 | A1 |
20050171487 | Haury et al. | Aug 2005 | A1 |
20050209555 | Middleton et al. | Sep 2005 | A1 |
20050228362 | Vaillancourt | Oct 2005 | A1 |
20050256460 | Rome et al. | Nov 2005 | A1 |
20050256461 | DiFiore et al. | Nov 2005 | A1 |
20050261637 | Miller | Nov 2005 | A1 |
20050261665 | Voorhees | Nov 2005 | A1 |
20050267445 | Mendels | Dec 2005 | A1 |
20060015086 | Rasmussen et al. | Jan 2006 | A1 |
20060025724 | Chen | Feb 2006 | A1 |
20060025751 | Roy et al. | Feb 2006 | A1 |
20060027270 | Truitt et al. | Feb 2006 | A1 |
20060047251 | Bickford-Smith et al. | Mar 2006 | A1 |
20060074386 | Wollmann | Apr 2006 | A1 |
20060089603 | Truitt et al. | Apr 2006 | A1 |
20060089604 | Guerrero | Apr 2006 | A1 |
20060089605 | Fitzgerald | Apr 2006 | A1 |
20060111694 | Fukai et al. | May 2006 | A1 |
20060129109 | Shaw et al. | Jun 2006 | A1 |
20060129112 | Lynn | Jun 2006 | A1 |
20060142735 | Whitley | Jun 2006 | A1 |
20060149213 | Raybuck | Jul 2006 | A1 |
20060161115 | Fangrow | Jul 2006 | A1 |
20060173420 | Fangrow | Aug 2006 | A1 |
20060178645 | Peppel | Aug 2006 | A1 |
20060184139 | Quigley et al. | Aug 2006 | A1 |
20060184140 | Okiyama | Aug 2006 | A1 |
20060200072 | Peppel | Sep 2006 | A1 |
20060200095 | Steube | Sep 2006 | A1 |
20060200096 | Fangrow | Sep 2006 | A1 |
20060206058 | Lopez | Sep 2006 | A1 |
20060206059 | Lopez | Sep 2006 | A1 |
20060211997 | Fangrow | Sep 2006 | A1 |
20060211998 | Fangrow | Sep 2006 | A1 |
20060211999 | Fangrow | Sep 2006 | A1 |
20060212000 | Fangrow | Sep 2006 | A1 |
20060212001 | Fangrow | Sep 2006 | A1 |
20060212002 | Fangrow | Sep 2006 | A1 |
20060212003 | Fangrow | Sep 2006 | A1 |
20060212005 | Fangrow | Sep 2006 | A1 |
20060212006 | Fangrow et al. | Sep 2006 | A1 |
20060217671 | Peppel | Sep 2006 | A1 |
20060217679 | Hanly et al. | Sep 2006 | A1 |
20060217683 | Patania | Sep 2006 | A1 |
20060229571 | Peppel | Oct 2006 | A1 |
20060229590 | Roy | Oct 2006 | A1 |
20060264842 | Fangrow | Nov 2006 | A1 |
20060264843 | Fangrow | Nov 2006 | A1 |
20060264844 | Fangrow | Nov 2006 | A1 |
20060264845 | Lopez | Nov 2006 | A1 |
20060264846 | Lopez | Nov 2006 | A1 |
20060264847 | Lopez | Nov 2006 | A1 |
20060264848 | Fangrow | Nov 2006 | A1 |
20060264890 | Moberg et al. | Nov 2006 | A1 |
20060264891 | Lopez | Nov 2006 | A1 |
20060264892 | Lopez | Nov 2006 | A1 |
20060264894 | Moberg et al. | Nov 2006 | A1 |
20060264908 | Ishii et al. | Nov 2006 | A1 |
20060264909 | Fangrow | Nov 2006 | A1 |
20060264910 | Fangrow | Nov 2006 | A1 |
20060270999 | Fangrow | Nov 2006 | A1 |
20060271012 | Canaud | Nov 2006 | A1 |
20060271015 | Mantell | Nov 2006 | A1 |
20060271016 | Fangrow | Nov 2006 | A1 |
20060276757 | Fangrow | Dec 2006 | A1 |
20060276758 | Fangrow | Dec 2006 | A1 |
20060287638 | Aneas | Dec 2006 | A1 |
20060287639 | Sharp | Dec 2006 | A1 |
20060293629 | Cote et al. | Dec 2006 | A1 |
20060293640 | Greco | Dec 2006 | A1 |
20070032775 | Niedospial et al. | Feb 2007 | A1 |
20070032776 | Skinner et al. | Feb 2007 | A1 |
20070038189 | Bartholomew | Feb 2007 | A1 |
20070043334 | Guala | Feb 2007 | A1 |
20070060898 | Shaughnessy et al. | Mar 2007 | A1 |
20070060902 | Brandenburger et al. | Mar 2007 | A1 |
20070060904 | Vedrine et al. | Mar 2007 | A1 |
20070073242 | Andersen et al. | Mar 2007 | A1 |
20070078393 | Lynch et al. | Apr 2007 | A1 |
20070078429 | Sharp | Apr 2007 | A1 |
20070083157 | Belley et al. | Apr 2007 | A1 |
20070088252 | Pestotnik et al. | Apr 2007 | A1 |
20070088292 | Fangrow | Apr 2007 | A1 |
20070088293 | Fangrow | Apr 2007 | A1 |
20070088294 | Fangrow | Apr 2007 | A1 |
20070088313 | Zinger et al. | Apr 2007 | A1 |
20070088324 | Fangrow | Apr 2007 | A1 |
20070088325 | Fangrow | Apr 2007 | A1 |
20070088327 | Guala | Apr 2007 | A1 |
20070093764 | Guerrero | Apr 2007 | A1 |
20070100294 | Sugita et al. | May 2007 | A1 |
20070112311 | Harding et al. | May 2007 | A1 |
20070112312 | Fangrow | May 2007 | A1 |
20070112313 | Fangrow | May 2007 | A1 |
20070112314 | Harding et al. | May 2007 | A1 |
20070112332 | Harding et al. | May 2007 | A1 |
20070112333 | Hoang et al. | May 2007 | A1 |
20070129705 | Trombley et al. | Jun 2007 | A1 |
20070156112 | Walsh | Jul 2007 | A1 |
20070156118 | Ramsey et al. | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
1105959 | Jul 1981 | CA |
855319 | Nov 1952 | DE |
8425197 | Oct 1985 | DE |
3740269 | Jun 1989 | DE |
0114677 | Aug 1984 | EP |
0237321 | Sep 1987 | EP |
0309771 | Apr 1989 | EP |
0367549 | Oct 1989 | EP |
0399119 | Nov 1990 | EP |
0438909 | Dec 1990 | EP |
0446463 | Dec 1990 | EP |
1733749 | Dec 2006 | EP |
2034185 | Jun 1980 | GB |
8601712 | Mar 1986 | WO |
8603416 | Jun 1986 | WO |
9311828 | Jun 1993 | WO |
9721463 | Jun 1997 | WO |
9721464 | Jun 1997 | WO |
9826835 | Jun 1998 | WO |
9958186 | Nov 1999 | WO |
0204065 | Jan 2002 | WO |
03086528 | Oct 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20080172005 A1 | Jul 2008 | US |